Next Generation Sequencing Global Market Opportunities and Strategies 2020-30: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global next generation sequencing market.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the next generation sequencing market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global next generation sequencing market opportunities and strategies to 2030 report answers all these questions and many more.
The report covers the following chapters
Markets Covered: The global next generation sequencing market is segmented by -
Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies; Pacific Biosciences of California Inc.; QIAGEN
Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Outperform competitors using accurate up to date demand-side dynamics information.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Identify growth segments for investment.
- Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
- Create regional and country strategies on the basis of local data and analysis.
- Stay abreast of the latest customer and market research findings
- Benchmark performance against key competitors.
- Develop strategies based on likely future developments.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Gain a global perspective on the development of the market.
Description:
Where is the largest and fastest growing market for the next generation sequencing market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global next generation sequencing market opportunities and strategies to 2030 report answers all these questions and many more.
The report covers the following chapters
- Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
- Report Structure - This section gives the structure of the report and the information covered in the various sections.
- Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by game type, and by device.
- Market Characteristics - The market characteristics section of the report defines and explains the next generation sequencing market. This chapter includes different goods covered in the report and basic definitions.
- Trends and Strategies - This chapter describes the major trends shaping the global next generation sequencing market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
- COVID Impact Analysis - This section provides an insight on how the pandemic is impacting the next generation sequencing market.
- Global Market Size and Growth - This section contains the global historic (2015-2019) and forecast (2019-2023, 2023-2025 and 2025-2030) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
- Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
- Market Segmentation - This section contains the market values (2015-2029, 2023, 2025 and 2030) and analysis for different segments and sub-segments in the market.
- Regional Market Size and Growth - This section contains the region’s market size (2019), historic and forecast (2015-2030) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
- Competitive Landscape - This section covers details on the competitive landscape of the global next generation sequencing market, estimated market shares and company profiles of the leading players.
- Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities and Strategies- This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
- Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for next generation sequencing providers in terms of product offerings, geographic expansion, price offerings, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered: The global next generation sequencing market is segmented by -
- By Product Type: Instruments; Kits and Consumables; Software
- By Application: Diagnostics; Drug Discovery; Others
- By Technology: Sequencing By Synthesis; Ion Semiconductor Sequencing; Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Others
Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies; Pacific Biosciences of California Inc.; QIAGEN
Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
1. Next Generation Sequencing Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
6. Introduction
7. Next Generation Sequencing Market Characteristics
8. Next Generation Sequencing Market Trends and Strategies
9. COVID-19 Impact on Next Generation Sequencing Market
10. Global Next Generation Sequencing Market Size and Growth
11. Next Generation Sequencing Market, Regional Analysis
12. Global Next Generation Sequencing Market Segmentation
13. Asia-Pacific Next Generation Sequencing Market
14. Western Europe Next Generation Sequencing Market
15. Eastern Europe Next Generation Sequencing Market
16. North America Next Generation Sequencing Market
17. South America Next Generation Sequencing Market
18. Middle East Next Generation Sequencing Market
19. Africa Next Generation Sequencing Market
20. Global Next Generation Sequencing Market Competitive Landscape
21. Key Mergers and Acquisitions in The Next Generation Sequencing Market
22. Next Generation Sequencing Market Opportunities and Strategies
23. Next Generation Sequencing Market, Conclusions and Recommendations
24. Appendix
Note: Product cover images may vary from those shown
The next generation sequencing market consists of sales of devices and equipment used in next generation sequencing and related services by entities (organizations, sole traders and partnerships) that manufacture next generation sequencing equipment. Next-generation sequencing (NGS) is an advanced sequencing technology that allows DNA and RNA to be sequenced much faster and more cost effectively than traditionally used sequencing, such as Sanger sequencing.
The global next generation sequencing market reached a value of nearly $6,678.3 million in 2019, having increased at a compound annual growth rate (CAGR) of 11.0% since 2015. The market is expected to grow from $6,678.3 million in 2019 to $12,612.1 million in 2023 at a rate of 17.2%. The growth is mainly due to the growing number of chronic diseases and government initiatives. The market is expected to grow from $12,612.1 million in 2023 to $17,763.7 million in 2025 at a CAGR of 18.7%. The market is expected to grow and reach $40,309.1 million in 2030 at a CAGR of 17.81%.
Growth in the historic period resulted from rise in funding, increased healthcare expenditure, emerging markets growth, rapid technological advances and rapid growth in elderly population. This growth was restricted by regulatory and data storage challenges.
Going forward, aging population, increase in healthcare access, rising prevalence of chronic diseases and increasing demand for next generation sequencing due to COVID-19 are expected to drive the market. Ethical concerns related to genomic study and high costs of tests are major factors that could hinder the growth of the next generation sequencing market in the future.
The next generation sequencing market is segmented by product type into instruments, kits and consumables and software. The kits and consumables was the largest segment of the next generation sequencing market segmented by product, accounting for 65.3% of the total market in 2019. Going forward, software is expected to be the fastest growing segment in the next generation sequencing market segmented by product type, at a CAGR of 23.9% during 2019-2023.
The next generation sequencing market is also segmented by application into diagnostics, drug discovery and others. The drug discovery was the largest segment of the next generation sequencing market segmented by application, accounting for 53.5% of the total market in 2019. Going forward, the other applications segment is expected to be the fastest growing segment in the next generation sequencing market segmented by application, at a CAGR of 15.5% during 2019-2023.
The next generation sequencing market is also segmented by technology into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing and others. The ion semiconductor sequencing was the largest segment of the next generation sequencing market segmented by technology, accounting for 75.8% of the total market in 2019. Going forward, the nanopore sequencing segment is expected to be the fastest growing segment in the next generation sequencing market segmented by technology, at a CAGR of 23.0% during 2019-2023.
North America was the largest region in the global next generation sequencing market, accounting for 34.7% of the total in 2019. It was followed by the Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the next generation sequencing market will be Eastern Europe and Asia Pacific, where growth will be at CAGRs of 21.6% and 20.1% respectively during 2019-2023. These will be followed by Africa and Middle East, where the markets are expected to register CAGRs of 17.6% and 17.2% respectively during 2019-2023.
The next generation sequencing market is fragmented, with a large number of small players in the market. The top ten competitors in the market made up to 49.8% of the total market in 2019. Major players in the market include Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Pacific Biosciences of California Inc., and QIAGEN.
The top opportunities in the next generation sequencing market segmented by product will arise in the kits and consumables segment, which will gain $3,731.2 million of global annual sales by 2023. The top opportunities in the next generation sequencing market segmented by application will arise in the drug discovery segment, which will gain $2,826.1 million of global annual sales by 2023. The top opportunities in the next generation sequencing market segmented by technology will arise in the ion semiconductor sequencing segment, which will gain $4,563.7 million of global annual sales by 2023 The next generation sequencing market size will gain the most in the USA at $1,671.3 million. Market-trend-based strategies for the next generation sequencing market includes focusing on using artificial intelligence to reduce costs and time, studying rare diseases in a cost-effective manner to maintain a competitive edge over other technologies, offering NGS technologies for newborn screening and adopting big data technologies to analyze large genomic data. Player-adopted strategies in the next generation sequencing market include investing in expanding operations through innovative product launches, and in acquisitions and mergers to strengthen their service offerings.
To take advantage of the opportunities, the publisher recommends the next generation sequencing companies to focus on Artificial Intelligence, invest in big data, expand in emerging markets, focus on premium pricing, and focus on increasing awareness of the benefits of next generation sequencing.
The global next generation sequencing market reached a value of nearly $6,678.3 million in 2019, having increased at a compound annual growth rate (CAGR) of 11.0% since 2015. The market is expected to grow from $6,678.3 million in 2019 to $12,612.1 million in 2023 at a rate of 17.2%. The growth is mainly due to the growing number of chronic diseases and government initiatives. The market is expected to grow from $12,612.1 million in 2023 to $17,763.7 million in 2025 at a CAGR of 18.7%. The market is expected to grow and reach $40,309.1 million in 2030 at a CAGR of 17.81%.
Growth in the historic period resulted from rise in funding, increased healthcare expenditure, emerging markets growth, rapid technological advances and rapid growth in elderly population. This growth was restricted by regulatory and data storage challenges.
Going forward, aging population, increase in healthcare access, rising prevalence of chronic diseases and increasing demand for next generation sequencing due to COVID-19 are expected to drive the market. Ethical concerns related to genomic study and high costs of tests are major factors that could hinder the growth of the next generation sequencing market in the future.
The next generation sequencing market is segmented by product type into instruments, kits and consumables and software. The kits and consumables was the largest segment of the next generation sequencing market segmented by product, accounting for 65.3% of the total market in 2019. Going forward, software is expected to be the fastest growing segment in the next generation sequencing market segmented by product type, at a CAGR of 23.9% during 2019-2023.
The next generation sequencing market is also segmented by application into diagnostics, drug discovery and others. The drug discovery was the largest segment of the next generation sequencing market segmented by application, accounting for 53.5% of the total market in 2019. Going forward, the other applications segment is expected to be the fastest growing segment in the next generation sequencing market segmented by application, at a CAGR of 15.5% during 2019-2023.
The next generation sequencing market is also segmented by technology into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing and others. The ion semiconductor sequencing was the largest segment of the next generation sequencing market segmented by technology, accounting for 75.8% of the total market in 2019. Going forward, the nanopore sequencing segment is expected to be the fastest growing segment in the next generation sequencing market segmented by technology, at a CAGR of 23.0% during 2019-2023.
North America was the largest region in the global next generation sequencing market, accounting for 34.7% of the total in 2019. It was followed by the Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the next generation sequencing market will be Eastern Europe and Asia Pacific, where growth will be at CAGRs of 21.6% and 20.1% respectively during 2019-2023. These will be followed by Africa and Middle East, where the markets are expected to register CAGRs of 17.6% and 17.2% respectively during 2019-2023.
The next generation sequencing market is fragmented, with a large number of small players in the market. The top ten competitors in the market made up to 49.8% of the total market in 2019. Major players in the market include Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Pacific Biosciences of California Inc., and QIAGEN.
The top opportunities in the next generation sequencing market segmented by product will arise in the kits and consumables segment, which will gain $3,731.2 million of global annual sales by 2023. The top opportunities in the next generation sequencing market segmented by application will arise in the drug discovery segment, which will gain $2,826.1 million of global annual sales by 2023. The top opportunities in the next generation sequencing market segmented by technology will arise in the ion semiconductor sequencing segment, which will gain $4,563.7 million of global annual sales by 2023 The next generation sequencing market size will gain the most in the USA at $1,671.3 million. Market-trend-based strategies for the next generation sequencing market includes focusing on using artificial intelligence to reduce costs and time, studying rare diseases in a cost-effective manner to maintain a competitive edge over other technologies, offering NGS technologies for newborn screening and adopting big data technologies to analyze large genomic data. Player-adopted strategies in the next generation sequencing market include investing in expanding operations through innovative product launches, and in acquisitions and mergers to strengthen their service offerings.
To take advantage of the opportunities, the publisher recommends the next generation sequencing companies to focus on Artificial Intelligence, invest in big data, expand in emerging markets, focus on premium pricing, and focus on increasing awareness of the benefits of next generation sequencing.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Pacific Biosciences of California Inc.
- QIAGEN
Note: Product cover images may vary from those shown
LOADING...